Chengdu Kangnuoxing Biopharma,inc.

This study looks at the safety of a drug called Stapokibart for people with chronic sinusitis and nasal polyps (CRSwNP). About 600 adults will receive the injection and be monitored for side effects. The goal is to check for any harmful reactions, not to cure the condition.

This study looks at how safe Stapokibart injection is for people with seasonal allergic rhinitis (SAR). About 400 adults will take part, and researchers will track any side effects. The goal is to see if the drug is safe enough for wider use.

This study tests a new injection called Stapokibart for adults with moderate-to-severe atopic dermatitis (eczema). Researchers will monitor 1,000 participants for side effects and how well the drug controls their skin condition. The goal is to see if this treatment is safe and ef…